文献速递妇科

BRCA状态与高级别浆液性卵巢癌初次肿瘤细胞减灭术完全切除的相关性

The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma.
PubMed 文献 · Gynecol Oncol · 2021-07-10

该回顾性研究纳入2000至2017年接受初次肿瘤细胞减灭术的303例III/IV期高级别浆液性卵巢癌患者,比较BRCA突变型与野生型的残留病灶情况。BRCA突变组达到无肉眼残留(0 mm)的比例为72%,野生型为48%(p<0.001);多因素模型中BRCA突变状态预测0 mm残留的OR为5.3(95%CI 2.45-11.5;p<0.001)。

要点

  • BRCA突变型HGSC患者初次减灭术达到0 mm残留的比例显著高于野生型(72% vs 48%)。
  • 校正年龄、手术时间、CA-125、分期、疾病负荷和手术复杂度后,BRCA突变状态仍独立预测完全切除。
  • 两组疾病负荷与围手术期并发症无差异,提示BRCA状态本身与手术可切除性相关。

核心结论

  • BRCA突变状态是高级别浆液性卵巢癌患者初次肿瘤细胞减灭术达到完全切除(0 mm残留)的预测因素。

研究设计与样本

  • 回顾性分析2000至2017年接受初次肿瘤细胞减灭术的III/IV期高级别浆液性卵巢癌患者,已知胚系和体细胞BRCA状态,共303例。

主要发现

  • 303例中BRCA突变型120例(40%),野生型183例(60%)。
  • BRCA突变组达到0 mm残留的比例为72%,野生型为48%(p<0.001)。
  • 多因素模型中,BRCA突变状态预测0 mm残留的OR为5.3(95%CI 2.45-11.5;p<0.001)。
  • 两组术前CA-125、疾病负荷、手术复杂度、手术时间和围手术期并发症无差异。

临床怎么用

  • 对于高级别浆液性卵巢癌患者,BRCA突变状态可辅助预测初次肿瘤细胞减灭术达到完全切除的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: BRCA-associated ovarian cancers are biologically unique; it is unclear if this translates to favorable outcomes at the time of primary cytoreduction (PCS). The aim of this study was to compare the amount of residual disease after PCS in BRCA mutated (BRCAm) and wild-type (BRCAwt) high-grade serous ovarian cancers (HGSC), and to assess whether BRCA status was an independent predictor of complete cytoreduction. METHODS: We conducted a retrospective analysis of patients with stage III/IV HGSC with known germline and somatic BRCA status, treated with PCS from 2000 to 2017. We compared the complete, optimal and suboptimal cytoreduction rates between the BRCAm and BRCAwt cohorts and built a predictive model to assess whether BRCA status was predictive of complete cytoreduction. RESULTS: Of 303 treated with PCS, 120 were germline/somatic BRCAm (40%) and 183 were BRCAwt (60%). BRCAm women tended to be younger, but there were no differences between the two groups in preoperative CA-125, disease burden, surgical complexity, length of surgery, or perioperative complications. BRCAm group had a higher rate of complete cytoreduction to no residual disease (0 mm) [72% vs. 48%] (p < 0.001). In a multivariate model, after accounting for age, length of surgery, CA-125 level, stage, disease burden and surgical complexity, BRCAm status was predictive of 0 mm residual disease with odds ratio of 5.3 (95% CI 2.45-11.5; p < 0.001). CONCLUSIONS: BRCAm status is predictive of complete cytoreduction at the time of PCS. Despite similar disease burden and surgical efforts, one is more likely to achieve complete resection in BRCAm HGSC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim SR, Malcolmson J, Li X, et al. The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma. Gynecol Oncol. 2021. PMID: 34256977. doi:10.1016/j.ygyno.2021.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。